240
Participants
Start Date
April 30, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Optimal Metabotype-specific diet
Following screening, baseline measurements, and determination of Metabotype, participants will be randomly assigned, using minimisation, to either the Precision Nutrition (PN) group or the Control (CN) group. The PN group will receive a diet hypothesised to be optimal for their specific Metabotype. All participants will adhere to their assigned diets for 12 months. Each Metabotype-specific diet will align with the Dutch Healthy Dietary Guidelines, while varying in macronutrient composition and quality.
Sub-optimal diet
Participants randomised to the Control Group (CN), will be randomly assigned one of the two diets optimised for a different Metabotype of the same sex. The assigned CN Group diet will always have a macronutrient content and quality that is different than their hypothesised optimal diet. All diets will align with the Dutch Healthy Dietary Guidelines.
Maastricht University Medical Center, Department of Human Biology, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht
Wageningen University and Research, Division of Human Nutrition, Wageningen
Collaborators (2)
Wageningen University and Research
OTHER
Health Holland
OTHER
TKI Agri & Food
UNKNOWN
Nestle Health Science
INDUSTRY
Beneo GmbH
INDUSTRY
BARILLA G. e R. Fratelli S.p.A., Parma, Italy
UNKNOWN
Maastricht University Medical Center
OTHER